Print

Agere Executives to Discuss Enhancing Oral Bioavailability Using Amorphous Molecular Dispersions at ExL Pharma's "Enhancing Drug Bioavailability and Solubility" Conference  
1/10/2013 9:10:34 AM

BEND, Ore.--(BUSINESS WIRE)--Agere Pharmaceuticals, Inc., a leading oral bioavailability contract research and manufacturing organization (CRO/CMO), will present, facilitate and participate in a panel discussion at ExL Pharma’s 2nd annual conference focused on solubility and bioavailability in Boston, January 21 – 23, 2013. www.exlpharma.com/bioavailability
//-->